Compounds for treatment of angiogenesis-mediated diseases
Abstract:
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0